Meeder Advisory Services’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$998K Sell
1,884
-37
-2% -$17.1K 0.04% 305
2026
Q1
$922K Buy
1,921
+17
+0.9% +$8.7K 0.04% 290
2025
Q4
$1.07M Buy
1,904
+61
+3% +$34.6K 0.05% 259
2025
Q3
$948K Buy
1,843
+7
+0.4% +$3.06K 0.04% 280
2025
Q2
$576K Buy
1,836
+993
+118% +$298K 0.03% 351
2025
Q1
$257K Buy
843
+153
+22% +$51.5K 0.02% 494
2024
Q4
$229K Buy
690
+20
+3% +$6.78K 0.01% 507
2024
Q3
$224K Buy
670
+46
+7% +$17.5K 0.01% 502
2024
Q2
$257K Buy
624
+56
+10% +$22.2K 0.02% 437
2024
Q1
$230K Buy
+568
New +$200K 0.02% 401

Other funds holding MEDP

Meeder Advisory Services's MEDP Position: Q2 2026 in Review

Meeder Advisory Services reduced its Medpace (MEDP) stake by 1.9% in Q2 2026, selling an estimated $17.1K and leaving 1,884 shares worth $998K. The position accounts for 0.04% of the portfolio, ranked #305.

Meeder Advisory Services first reported a position in MEDP in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.07M in Q4 2025. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Meeder Advisory Services held 1,884 shares of Medpace worth $998K as of Q2 2026.
  • Meeder Advisory Services sold 37 Medpace shares in Q2 2026, an estimated $17.1K.
  • Medpace made up 0.04% of Meeder Advisory Services's portfolio in Q2 2026, its #305 holding.
  • Meeder Advisory Services first reported a position in Medpace in Q1 2024 and has held it in 10 quarters since.
  • Meeder Advisory Services's Medpace position peaked at $1.07M in Q4 2025.
  • 700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.